Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Risk for renal cell carcinoma in chronic hepatitis C infection.

Gordon SC, Moonka D, Brown KA, Rogers C, Huang MA, Bhatt N, Lamerato L.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1066-73. doi: 10.1158/1055-9965.EPI-09-1275. Epub 2010 Mar 23.

2.

Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.

Tsui JI, Vittinghoff E, Shlipak MG, Bertenthal D, Inadomi J, Rodriguez RA, O'Hare AM.

Arch Intern Med. 2007 Jun 25;167(12):1271-6.

PMID:
17592100
3.

Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C.

Hamada H, Yatsuhashi H, Yano K, Daikoku M, Arisawa K, Inoue O, Koga M, Nakata K, Eguchi K, Yano M.

Cancer. 2002 Jul 15;95(2):331-9.

4.

Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.

d'Arminio Monforte A, Cozzi-Lepri A, Castagna A, Antinori A, De Luca A, Mussini C, Caputo SL, Arlotti M, Magnani G, Pellizzer G, Maggiolo F, Puoti M; Icona Foundation Study Group.

Clin Infect Dis. 2009 Aug 15;49(4):612-22. doi: 10.1086/603557.

PMID:
19591597
5.

Chronic hepatitis C infection as a risk factor for renal cell carcinoma.

Gonzalez HC, Lamerato L, Rogers CG, Gordon SC.

Dig Dis Sci. 2015 Jun;60(6):1820-4. doi: 10.1007/s10620-015-3521-3. Epub 2015 Jan 17.

PMID:
25592719
6.

Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis.

Satoh S, Tsuchiya N, Habuchi T, Ishiyama T, Seimo K, Kato T.

J Urol. 2005 Nov;174(5):1749-53.

PMID:
16217276
7.

History of urinary tract infection and risk of renal cell carcinoma.

Parker AS, Cerhan JR, Lynch CF, Leibovich BC, Cantor KP.

Am J Epidemiol. 2004 Jan 1;159(1):42-8.

PMID:
14693658
8.

A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.

Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, Wang KJ, Dai LP, Han SG, Zhou YF, Zhuang H.

Int J Epidemiol. 1998 Aug;27(4):574-8.

PMID:
9758109
9.

Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.

Canavese C, Hollò Z, Ciccone G, Ghisetti V, Barbui A, Fop F, Martina G, Forgnone F, Novo P, Thea A, Grill A, Marchiaro G.

J Nephrol. 2000 Sep-Oct;13(5):352-9.

PMID:
11063139
10.

Lack of association between renal cell carcinoma and non-Hodgkin's lymphoma.

Rabbani F, Russo P.

Urology. 1999 Jul;54(1):28-33.

PMID:
10414722
11.

Frequency of HCV infection in renal cell carcinoma patients.

Budakoğlu B, Aksoy S, Arslan Ç, Üyetürk Ü, Babacan NA, Özcan MF, Yıldız R, Öven BB, Özdemir NY, Dizdar Ö, Büyükberber S, Akıncı MB, Türker I, Öksüzoğlu B, Altundag K, Zengin N.

Med Oncol. 2012 Sep;29(3):1892-5. doi: 10.1007/s12032-011-9928-6. Epub 2011 Apr 3.

PMID:
21461964
12.

Renal cell carcinoma in dialysis patients: a single center experience.

Kojima Y, Takahara S, Miyake O, Nonomura N, Morimoto A, Mori H.

Int J Urol. 2006 Aug;13(8):1045-8.

13.

Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis.

Acalovschi M, Buzas C, Radu C, Grigorescu M.

J Viral Hepat. 2009 Dec;16(12):860-6. doi: 10.1111/j.1365-2893.2009.01141.x. Epub 2009 May 26.

PMID:
19486279
14.

Association of diabetes mellitus and chronic hepatitis C virus infection.

Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, Guo L, Jacob S, Regenstein FG, Zimmerman R, Everhart JE, Wasserfall C, Maclaren NK, Perrillo RP.

Hepatology. 1999 Feb;29(2):328-33.

PMID:
9918906
15.

Hospitalization rates differ by hepatitis C satus in an urban HIV cohort.

Gebo KA, Diener-West M, Moore RD.

J Acquir Immune Defic Syndr. 2003 Oct 1;34(2):165-73.

PMID:
14526205
16.

Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.

Lai MS, Hsieh MS, Chiu YH, Chen TH.

Hepatology. 2006 Jun;43(6):1295-302.

PMID:
16729295
17.

8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.

Chuma M, Hige S, Nakanishi M, Ogawa K, Natsuizaka M, Yamamoto Y, Asaka M.

J Gastroenterol Hepatol. 2008 Sep;23(9):1431-6. doi: 10.1111/j.1440-1746.2008.05502.x.

PMID:
18854000
18.

Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study.

Beisland C, Talleraas O, Bakke A, Norstein J.

BJU Int. 2006 Apr;97(4):698-702.

19.

Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients.

Lemos LB, Perez RM, Lemos MM, Draibe SA, Silva IS, Silva AE, Ferraz ML.

Nephron Clin Pract. 2008;108(2):c135-40. doi: 10.1159/000114452. Epub 2008 Jan 30.

PMID:
18230916
20.

Family history and risk of renal cell carcinoma.

Gago-Dominguez M, Yuan JM, Castelao JE, Ross RK, Yu MC.

Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):1001-4.

Supplemental Content

Support Center